Literature DB >> 16107960

A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections.

John V Williams1, Rodrigo Martino, Núria Rabella, Magdalena Otegui, Rocio Parody, Joshua M Heck, James E Crowe.   

Abstract

Human metapneumovirus (hMPV) is a recently described paramyxovirus associated with upper and lower respiratory-tract infection (URI and LRI, respectively). We conducted a prospective study of URI and LRI in adults with hematologic malignancies during a 4-year period. We retrospectively tested samples by reverse-transcription polymerase chain reaction for hMPV and analyzed clinical data. Twenty-two (9%) of 251 episodes of respiratory infection tested positive for hMPV. Sixteen (73%) of the illnesses occurred in hematopoietic stem-cell transplant recipients. Nine patients with hMPV developed LRI; 3 of these patients died. hMPV is a common cause of respiratory infections in adults with hematologic malignancies, with associated morbidity and mortality.

Entities:  

Mesh:

Year:  2005        PMID: 16107960      PMCID: PMC1483060          DOI: 10.1086/432732

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults.

Authors:  B L Jones; S Clark; E T Curran; S McNamee; G Horne; B Thakker; J Hood
Journal:  J Hosp Infect       Date:  2000-01       Impact factor: 3.926

2.  Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups.

Authors:  Guy Boivin; Yacine Abed; Gilles Pelletier; Louisette Ruel; Danielle Moisan; Stéphanie Côté; Teresa C T Peret; Dean D Erdman; Larry J Anderson
Journal:  J Infect Dis       Date:  2002-10-08       Impact factor: 5.226

3.  Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease.

Authors:  P A Cane; B G van den Hoogen; S Chakrabarti; C D Fegan; A D M E Osterhaus
Journal:  Bone Marrow Transplant       Date:  2003-02       Impact factor: 5.483

4.  Respiratory virus infections in bone marrow transplant recipients: the European perspective.

Authors:  P Ljungman
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

5.  Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience.

Authors:  R A Bowden
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

6.  Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children.

Authors:  Frank Esper; Derek Boucher; Carla Weibel; Richard A Martinello; Jeffrey S Kahn
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

7.  Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit.

Authors:  M Zambon; T Bull; C J Sadler; J M Goldman; K N Ward
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

8.  Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child.

Authors:  Gilles Pelletier; Pierre Déry; Yacine Abed; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

9.  Respiratory virus infections in adults with hematologic malignancies: a prospective study.

Authors:  Rodrigo Martino; Elena Rámila; Núria Rabella; José Manuel Muñoz; Mercé Peyret; José Manuel Portos; Rosario Laborda; Jorge Sierra
Journal:  Clin Infect Dis       Date:  2002-12-09       Impact factor: 9.079

10.  Children with respiratory disease associated with metapneumovirus in Hong Kong.

Authors:  J S Malik Peiris; Wing-Hong Tang; Kwok-Hung Chan; Pek-Lan Khong; Yi Guan; Yu-Lung Lau; Susan S Chiu
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more
  79 in total

1.  Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer.

Authors:  B Huck; M Egger; H Bertz; G Peyerl-Hoffman; W V Kern; D Neumann-Haefelin; V Falcone
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Human metapneumovirus infection as an emerging pathogen causing acute respiratory distress syndrome.

Authors:  Luregn Jan Schlapbach; Philipp Agyeman; Damian Hutter; Christoph Aebi; Bendicht Peter Wagner; Thomas Riedel
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

3.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

Review 4.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

5.  Recovery of avian metapneumovirus subgroup C from cDNA: cross-recognition of avian and human metapneumovirus support proteins.

Authors:  Dhanasekaran Govindarajan; Ursula J Buchholz; Siba K Samal
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors:  Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Am J Blood Res       Date:  2012-11-25

7.  Population-based incidence of human metapneumovirus infection among hospitalized children.

Authors:  John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

8.  The Tennessee Children's Respiratory Initiative: Objectives, design and recruitment results of a prospective cohort study investigating infant viral respiratory illness and the development of asthma and allergic diseases.

Authors:  Tina V Hartert; Kecia Carroll; Tebeb Gebretsadik; Kimberly Woodward; Patricia Minton
Journal:  Respirology       Date:  2010-03-29       Impact factor: 6.424

9.  An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats.

Authors:  Hoyin Mok; Sharon J Tollefson; Amy B Podsiad; Bryan E Shepherd; Vasiliy V Polosukhin; Robert E Johnston; John V Williams; James E Crowe
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Rohith Piyaratna; Linda D Lintao; Marla Chu; Alexis Liem; Mary Mark; Richard R Spaete; James E Crowe; John V Williams
Journal:  Virol J       Date:  2009-09-09       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.